BioSpace News Archive

Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, provided a corporate update, including a review of its pipeline and financial guidance.

argenx, a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, announced that it will host a conference call and audio webcast on Thursday, July 28, 2022 at 2:30 pm CET to discuss its half year 2022 financial results and provide a second quarter business update.

The life science group Sartorius increased sales revenue and earnings with double-digit growth rates in the first half of 2022 and confirmed its full-year outlook.

Addex Therapeutics Ltd announced the reduction of the nominal value of its issued, authorized and conditional share capital from CHF 1.00 to CHF 0.01, following the expiration of a period of two months after the third creditor call in The Swiss Gazette of Commerce in accordance with article 732 of Swiss Code of Obligations.

Sartorius Stedim Biotech, a leading partner of the biopharma industry, increased sales revenue and earnings with double-digit growth rates in the first half of 2022 and confirmed its full-year outlook.

The global Cri-du-chat syndrome treatment market is projected to expand at a favorable rate from 2021 to 2031.